e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
Biomarkers and diagnosis of allergic inflammatory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Analysis of SpA in exhaled particles
P. Larsson, E. Mirgorodskaya, L. Andersson, A. Bredberg, A. C. Almstrand, E. Ljungström, A. C. Olin (Gothenburg, Sweden)
Source:
Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases
Session:
Biomarkers and diagnosis of allergic inflammatory diseases
Session type:
Oral Presentation
Number:
5357
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Larsson, E. Mirgorodskaya, L. Andersson, A. Bredberg, A. C. Almstrand, E. Ljungström, A. C. Olin (Gothenburg, Sweden). Analysis of SpA in exhaled particles. Eur Respir J 2010; 36: Suppl. 54, 5357
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Risk factors associated with the development of interstitial lung abnormalities
Early detection of lung cancer in exhaled breath condensate using miRNA markers
Is snoring the cause of oxidative stress in airways in obstructive sleep apnea patients?
Related content which might interest you:
Proteomic analysis of exhaled endogenous particles non-invasively sampled from the airways
Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances
Year: 2010
Clinical evaluation of exhaled nitric oxide measurement in monitoring childhood asthma
Source: Annual Congress 2010 - Functional assessment of paediatric lung disease
Year: 2010
Analysis of exhaled breath condensate cytokine pattern in lung transplant recipients with and without BOS
Source: Annual Congress 2010 - Mechanisms of late allograft dysfunction: new insights
Year: 2010
Relationship between exhaled nitric oxide and exacerbation frequency in COPD patients: A longitudinal study
Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases
Year: 2011
Monitoring of 24-hours variation of leukotrienes in exhaled breath condensate
Source: Annual Congress 2007 - Acute and chronic effects of air pollution
Year: 2007
Effects of concentrated ambient air particles (CAPs) on markers of airways inflammation in exhaled breath condensate of healthy volunteers
Source: Eur Respir J 2004; 24: Suppl. 48, 237s
Year: 2004
Exhaled air analysis
Source: International Congress 2016 – New tools for the early diagnosis of acute respiratory distress syndrome
Year: 2016
Exhaled particles in healthy subjects and asthma patients – a new method for analysis of exhaled air
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
Biomarkers in asthma and COPD
Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine
Year: 2011
Protein pattern of exhaled breath condensate (EBC) and saliva
Source: Eur Respir J 2001; 18: Suppl. 33, 461s
Year: 2001
Methodology of exhaled breath condensate
Source: Annual Congress 2009 - Noninvasive monitoring of airway inflammation: beyond exhaled nitric oxide
Year: 2009
Monitoring airway inflammation after allergen challenge by measuring 8-isoprostane in exhaled breath condensate
Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases
Year: 2010
Correlation of LTB
4
with α-amylase in exhaled breath condensate
Source: Eur Respir J 2005; 26: Suppl. 49, 372s
Year: 2005
Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates
Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow
Year: 2008
Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Validation of eicosanoid measurements in exhaled breath condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 422s
Year: 2002
Determinants of variability in exhaled breath condensate (EBC) in children
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008
External validation of exhaled breath molecular profiling in identifying COPD and asthma
Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances
Year: 2010
Increased exhaled nitric oxide predicts new-onset rhinitis in asymptomatic children
Source: Annual Congress 2011 - Clinical application of exhaled biomarkers
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept